Anti-inflammatory effects of tretinoin (all-trans-retinoic acid) 0.1% and adapalene 0.1% in rats

Clinical and Experimental Dermatology

Volumn 30, Issue 5, 2005, Pages 570-572

  Akdeniz, Necmettin ^a,b   Calka O ^a   Ozbek H ^a   Metin, A ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b Hafiziye Mh Arastirma Hastanesi Arkasi ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACNELYSE; ADAPALENE; CARRAGEENAN; ETODOLAC; ETOL; INDOMETACIN; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; DERMATITIS; EDEMA; FEMALE; MALE; NAPHTHALENES; RATS; RATS, SPRAGUE-DAWLEY; TRETINOIN;

EID: 23044434430     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01859.x     Document Type: Article

References (12)

1. Sekula-Gibbs S, Uptmore D, Otillar L. Retinoids. J Am Acad Dermatol 2004; 50: 405-15.
2. Winter CA, Risley EA, Nuss GW. Carragenin-induced edema in hind paw of the rats as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 544-7.
3. Datta PK, Lianos EA. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. Kidney Int 1999; 56: 486-93.
4. Devaux Y, Grosjean S, Seguin C et al. Retinoic acid and hostpathogen interactions: effects on inducible nitric oxide synthase in vivo. Am J Physiol Endocrinol Metab 2000; 279: 1045-53.
5. Juan JM. Effect of retinoids on dermal inflammation and on arachidonic acid mobilization and metabolism in murine 3T6 fibroblasts retinoids, arachidonate release and metabolism. Int J Immunopharmacol 1996; 18: 459-65.
6. Martin JH, Alalami O, Yaqoob F. Differential effects of retinoids on nitric oxide production by promonocytic U937 cells and ZR-75-1 human breast cancer cells. Oncol Rep 2000; 7: 219-23.
7. Wauben-Penris PJ, Cerneus DP, van den Hoven WE et al. Immunomodulatory effects of tretinoin in combination with clindamycin. J Eur Acad Dermatol Venereol 1998; 11: 2-7.
8. Dillehay DL, Walia AS, Lamon EW. Effects of retinoids on macrophage function and IL-1 activity. J Leukoc Biol 1988; 44: 353-60.
9. Hensby C, Cavey D, Bouclier M et al. The in vivo and in vitro anti-inflammatory activity of CD271: a new retinoid-like modulator of cell differentiation. Agents Actions 1990; 29: 56-8.
10. Grosshans E, Marks R, Mascaro JM et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998; 139: 26-33.
11. Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol 1998; 52: 48-56.
12. Nyirady J, Grossman RM, Nighland M et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatol Treat 2001; 12: 149-57.